Literature DB >> 20410682

Community-based lifestyle modification of cardiovascular disease risks in middle-aged Japanese: a 27-month update.

Hiroko Fujii1, Takashi Muto, Yasuo Haruyama, Makiko Nakade, Emiko Kobayashi, Kaori Ishisaki, Akiko Yamasaki.   

Abstract

Lifestyle modification is the cornerstone of preventive management for people with cardiovascular disease risks, such as obesity, hypertension, dyslipidemia and diabetes. This study investigated the effect of a 27-month community-based lifestyle intervention on the reduction of cardiovascular disease risks in middle-aged Japanese. Of 549 participants with cardiovascular disease risk factors of overweight, hypertension, dyslipidemia or diabetes enrolled in this non-randomized controlled study, 397 participants aged 39-71 years old completed all 3 serial surveys at baseline, 15 months and 27 months. For the intervention group (39 males and 174 females), 31 specific interventions including individual counselling and group sessions were conducted. The control group (64 males and 120 females) only received 7 newsletters providing health information and results of health checkups. Multiple logistic regression analysis adjusted for sex, each baseline risk category and age category showed that the proportion of those who were overweight or showed dyslipidemia risk were significantly lower in the intervention group only at 27 months [Odds ratio (OR): 0.43 (95% CI 0.20-0.94), OR: 0.43 (95% CI 0.21-0.87), respectively] and the proportion of those showing diabetes risk was significantly lower in the intervention group at both 15 months [OR: 0.42 (95% CI 0.18-0.97)] and 27 months [OR: 0.56 (95% CI 0.32-0.99)]. In conclusion, the 27-month community-based lifestyle modification of cardiovascular disease risks shows significant reductions in risks of diabetes, overweight and dyslipidemia in middle-aged Japanese.

Entities:  

Mesh:

Year:  2010        PMID: 20410682     DOI: 10.1620/tjem.220.307

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  5 in total

1.  Antihypertensive medication versus health promotion for improving metabolic syndrome in preventing cardiovascular events: a success rate-oriented simulation study.

Authors:  Yoichi Ohno; Satomi Shibazaki; Ryuichiro Araki; Takashi Miyazaki; Mayuko Hanyu; Makiko Satoh; Tsuneo Takenaka; Hirokazu Okada; Hiromichi Suzuki
Journal:  BMC Med Inform Decis Mak       Date:  2011-02-13       Impact factor: 2.796

Review 2.  Lipid-lowering therapy: who can benefit?

Authors:  Sandra J Lewis
Journal:  Vasc Health Risk Manag       Date:  2011-08-24

3.  Efficacy and Patient Satisfaction of Dipeptidyl Peptidase-4 Inhibitor After Switching From Once-Daily DPP-4 Inhibitor to Once-Weekly Regimen.

Authors:  Katsunori Suzuki; Kazuki Hasegawa; Mio Watanabe
Journal:  J Clin Med Res       Date:  2018-06-27

4.  Evaluation of a community intervention program in Japan using Framingham risk score and estimated 10-year coronary heart disease risk as outcome variables: a non-randomized controlled trial.

Authors:  Bing Zhu; Yasuo Haruyama; Takashi Muto; Akiko Yamasaki; Fumiko Tarumi
Journal:  BMC Public Health       Date:  2013-03-11       Impact factor: 3.295

5.  Lifestyle intervention might easily improve blood pressure in hypertensive men with the C genotype of angiotensin II type 2 receptor gene.

Authors:  Kaori Kitaoka; Azusa Kitade; Junko Nagaoka; Kokoro Tsuzaki; Kiyomi Harada; Wataru Aoi; Sayori Wada; Hiroaki Asano; Naoki Sakane; Akane Higashi
Journal:  Nutr Res Pract       Date:  2015-06-19       Impact factor: 1.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.